Zdrowie i gospodarka · 22/04/2016
FDA Extends Comment Period for Human Cells, Tissues, and Cellular and Tissue-Based Products Guidance Documents
The FDA is extending the comment period for four draft guidance documents to allow more time for public input and submission of new information.